Relative susceptibilities of male germ cells to genetic defects induced by cancer chemotherapies
Journal Article
·
· Journal of the National Cancer Institute
OSTI ID:875374
Some chemotherapy regimens include agents that are mutagenic or clastogenic in model systems. This raises concerns that cancer survivors, who were treated before or during their reproductive years, may be at increased risks for abnormal reproductive outcomes. However, the available data from offspring of cancer survivors are limited, representing diverse cancers, therapies, time-to-pregnancies, and reproductive outcomes. Rodent breeding data after paternal exposures to individual chemotherapeutic agents illustrate the complexity of factors that influence the risk for transmitted genetic damage including agent, dose, endpoint, and the germ-cell susceptibility profiles that vary across agents. Direct measurements of chromosomal abnormalities in sperm of mice and humans by sperm FISH have corroborated the differences in germ-cell susceptibilities. The available evidence suggests that the risk of producing chromosomally defective sperm is highest during the first few weeks after the end of chemotherapy, and decays with time. Thus, sperm samples provided immediately after the initiation of cancer therapies may contain treatment-induced genetic defects that will jeopardize the genetic health of offspring.
- Research Organization:
- Lawrence Livermore National Laboratory (LLNL), Livermore, CA
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- W-7405-ENG-48
- OSTI ID:
- 875374
- Report Number(s):
- UCRL-JRNL-204915
- Journal Information:
- Journal of the National Cancer Institute, Journal Name: Journal of the National Cancer Institute Vol. 34; ISSN JNCIAM; ISSN 0198-0157
- Country of Publication:
- United States
- Language:
- English
Similar Records
Mechanisms and consequences of paternally transmitted chromosomal abnormalities
Meiotic susceptibility for induction of sperm with chromosomal aberrations in patients receiving combination chemotherapy for Hodgkin lymphoma
Journal Article
·
Tue Apr 05 00:00:00 EDT 2005
· Birth Defects Research Part C: Embryo Today
·
OSTI ID:875371
Meiotic susceptibility for induction of sperm with chromosomal aberrations in patients receiving combination chemotherapy for Hodgkin lymphoma
Journal Article
·
Sun Dec 27 19:00:00 EST 2020
· PLoS ONE
·
OSTI ID:1749970